Effects on blood pressure and autonomic nervous system function of a 12-week exercise or exercise plus DASH-diet intervention in individuals with elevated blood pressure

Acta Physiologica

Volumn 203, Issue 3, 2011, Pages 343-350

  Edwards, K M ^a,b   Wilson, K L ^b   Sadja, J ^b   Ziegler, M G ^c   Mills, P J ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Autonomic nervous system; Heart rate recovery; Hypertension; Parasympathetic nervous system

Indexed keywords

CATECHOLAMINE; NORADRENALIN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE REGULATION; BODY MASS; CALORIC INTAKE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DIET THERAPY; EARLY INTERVENTION; EXERCISE; EXERCISE INTENSITY; EXERCISE TEST; FEMALE; HEART RATE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; NORADRENALIN BLOOD LEVEL; PARASYMPATHETIC TONE; PRIORITY JOURNAL; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL MARKERS; BLOOD PRESSURE; CALIFORNIA; COMBINED MODALITY THERAPY; EXERCISE TEST; EXERCISE THERAPY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; NOREPINEPHRINE; RECOVERY OF FUNCTION; RISK REDUCTION BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME;

EID: 80054002430     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02329.x     Document Type: Article

References (42)

1. Adamopoulos, S., Parissis, J., Karatzas, D., Kroupis, C., Georgiadis, M., Karavolias, G., Paraskevaidis, J., Koniavitou, K., Coats, A.J. & Kremastinos, D.T. 2002. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol 39, 653-663.
2. Bacon, S.L., Sherwood, A., Hinderliter, A. & Blumenthal, J.A. 2004. Effects of exercise, diet and weight loss on high blood pressure. Sports Med 34, 307-316.
3. Blumenthal, J.A., Babyak, M.A., Hinderliter, A., Watkins, L.L., Craighead, L., Lin, P.H., Caccia, C., Johnson, J., Waugh, R. & Sherwood, A. 2010. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 170, 126-135.
4. Borg, G. 1971. The perception of physical performance. In: R.J. Shephard (ed.) Frontiers of Fitness, pp. 280-294. Charles C. Thomas, Springfield, IL.
5. Brown, M.D., Dengel, D.R., Hogikyan, R.V. & Supiano, M.A. 2002. Sympathetic activity and the heterogenous blood pressure response to exercise training in hypertensives. J Appl Physiol 92, 1434-1442.
6. Buch, A.N., Coote, J.H. & Townend, J.N. 2002. Mortality, cardiac vagal control and physical training - what's the link? Exp Physiol 87, 423-435.
7. Chobanian, A.V. 2009. Shattuck Lecture. The hypertension paradox - more uncontrolled disease despite improved therapy. N Engl J Med 361, 878-887.
8. Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. Jr, Jones, D.W., Materson, B.J., Oparil, S., Wright, J.T. Jr. & Roccella, E.J. 2003. The Seventh Report of the Joint National Committee on Prevention, Detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289, 2560-2572.
9. Collier, S.R., Kanaley, J.A., Carhart, R. Jr, Frechette, V., Tobin, M.M., Bennett, N., Luckenbaugh, A.N. & Fernhall, B. 2009. Cardiac autonomic function and baroreflex changes following 4weeks of resistance versus aerobic training in individuals with pre-hypertension. Acta Physiol (Oxf) 195, 339-348.
10. Edwards, K.M., Ziegler, M.G. & Mills, P.J. 2007. The potential anti-inflammatory benefits of improving physical fitness in hypertension. J Hypertens 25, 1533-1542.
11. Erdogan, D., Gonul, E., Icli, A., Yucel, H., Arslan, A., Akcay, S. & Ozaydin, M. 2010. Effects of normal blood pressure, prehypertension, and hypertension on autonomic nervous system function. Int J Cardiol In press, doi:10.1016/j.ijcard.2010.04.079.
12. Esler, M. 2010. The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 108, 227-237.
13. Fraga, R., Franco, F.G., Roveda, F., de Matos, L.N., Braga, A.M., Rondon, M.U., Rotta, D.R., Brum, P.C., Barretto, A.C., Middlekauff, H.R. & Negrao, C.E. 2007. Exercise training reduces sympathetic nerve activity in heart failure patients treated with carvedilol. Eur J Heart Fail 9, 630-636.
14. Grassi, G. 2009. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 54, 690-697.
15. Grassi, G., Seravalle, G., Calhoun, D.A. & Mancia, G. 1994. Physical training and baroreceptor control of sympathetic nerve activity in humans. Hypertension 23, 294-301.
16. Grassi, G., Seravalle, G. & Quarti-Trevano, F. 2010. The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol 95, 581-586.
17. Hamilton, C.A., Brosnan, M.J., McIntyre, M., Graham, D. & Dominiczak, A.F. 2001. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37, 529-534.
18. Herring, N. & Paterson, D.J. 2001. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro. J Physiol 535, 507-518.
19. Hodson, L., Harnden, K.E., Roberts, R., Dennis, A.L. & Frayn, K.N. 2010. Does the DASH diet lower blood pressure by altering peripheral vascular function? J Hum Hypertens 24, 312-319.
20. Joyner, M.J. & Green, D.J. 2009. Exercise protects the cardiovascular system: effects beyond traditional risk factors. J Physiol 587, 5551-5558.
21. Julius, S. & Majahalme, S. 2000. The changing face of sympathetic overactivity in hypertension. Ann Med 32, 365-370.
22. Kennedy, B. & Ziegler, M.G. 1990. A more sensitive and specific radioenzymatic assay for catecholamines. Life Sci 47, 2143-2153.
23. Kimura, H., Kon, N., Furukawa, S., Mukaida, M., Yamakura, F., Matsumoto, K., Sone, H. & Murakami-Murofushi, K. 2010. Effect of endurance exercise training on oxidative stress in spontaneously hypertensive rats (SHR) after emergence of hypertension. Clin Exp Hypertens 32, 407-415.
24. Kornet, L., Hoeks, A.P., Janssen, B.J., Houben, A.J., De Leeuw, P.W. & Reneman, R.S. 2005. Neural activity of the cardiac baroreflex decreases with age in normotensive and hypertensive subjects. J Hypertens 23, 815-823.
25. Lahiri, M.K., Kannankeril, P.J. & Goldberger, J.J. 2008. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol 51, 1725-1733.
26. Lesniak, K.T. & Dubbert, P.M. 2001. Exercise and hypertension. Curr Opin Cardiol 16, 356-359.
27. Loimaala, A., Huikuri, H., Oja, P., Pasanen, M. & Vuori, I. 2000. Controlled 5-mo aerobic training improves heart rate but not heart rate variability or baroreflex sensitivity. J Appl Physiol 89, 1825-1829.
28. Madhi, S.A., Adrian, P., Kuwanda, L., Jassat, W., Jones, S., Little, T., Soininen, A., Cutland, C. & Klugman, K.P. 2007. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine 25, 2451-2457.
29. Mancia, G., Grassi, G., Giannattasio, C. & Seravalle, G. 1999. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 34, 724-728.
30. Marsland, A.L., Gianaros, P.J., Prather, A.A., Jennings, J.R., Neumann, S.A. & Manuck, S.B. 2007. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom Med 69, 709-716.
31. Monahan, K.D., Dinenno, F.A., Tanaka, H., Clevenger, C.M., DeSouza, C.A. & Seals, D.R. 2000. Regular aerobic exercise modulates age-associated declines in cardiovagal baroreflex sensitivity in healthy men. J Physiol 529(Pt 1), 263-271.
32. Mora, S., Cook, N., Buring, J.E., Ridker, P.M. & Lee, I.M. 2007. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 116, 2110-2118.
33. Palatini, P. & Julius, S. 2009. The role of cardiac autonomic function in hypertension and cardiovascular disease. Curr Hypertens Rep 11, 199-205.
34. Pescatello, L.S., Franklin, B.A., Fagard, R., Farquhar, W.B., Kelley, G.A. & Ray, C.A. 2004. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 36, 533-553.
35. Polonia, J., Amaral, C., Bertoquini, S. & Martins, L. 2006. Attenuation of heart rate recovery after exercise in hypertensive patients with blunting of the nighttime blood pressure fall. Int J Cardiol 106, 238-243.
36. Routledge, F.S., Campbell, T.S., McFetridge-Durdle, J.A. & Bacon, S.L. 2010. Improvements in heart rate variability with exercise therapy. Can J Cardiol 26, 303-312.
37. Singh, J.P., Larson, M.G., Tsuji, H., Evans, J.C., O'Donnell, C.J. & Levy, D. 1998. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 32, 293-297.
38. Somers, V.K., Conway, J., Johnston, J. & Sleight, P. 1991. Effects of endurance training on baroreflex sensitivity and blood pressure in borderline hypertension. Lancet 337, 1363-1368.
39. Tracey, K.J. 2002. The inflammatory reflex. Nature 420, 853-859.
40. Tsai, J.C., Chang, W.Y., Kao, C.C., Lu, M.S., Chen, Y.J. & Chan, P. 2002. Beneficial effect on blood pressure and lipid profile by programmed exercise training in Taiwanese patients with mild hypertension. Clin Exp Hypertens 24, 315-324.
41. Wallin, B.G., Thompson, J.M., Jennings, G.L. & Esler, M.D. 1996. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol 491(Pt 3), 881-887.
42. Wegge, J.K., Roberts, C.K., Ngo, T.H. & Barnard, R.J. 2004. Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease. Metabolism 53, 377-381.